112 related articles for article (PubMed ID: 10653903)
21. Molecular cytogenetic analysis of the breakpoint region at 6q21-22 in T-cell lymphoma/leukemia cell lines.
Tagawa H; Miura I; Suzuki R; Suzuki H; Hosokawa Y; Seto M
Genes Chromosomes Cancer; 2002 Jun; 34(2):175-85. PubMed ID: 11979551
[TBL] [Abstract][Full Text] [Related]
22. Cryptic 6q subtelomeric deletion associated with a paracentric inversion in a mildly retarded child.
Lorda-Sanchez I; Lopez-Pajares I; Roche MC; Sanz R; Rodriguez de Alba M; Gonzalez-Gonzalez MC; Ibañez A; Ramos C; Ayuso C
Am J Med Genet; 2000 Dec; 95(4):336-8. PubMed ID: 11186887
[TBL] [Abstract][Full Text] [Related]
23. Analysis of chromosome 6q deletion in EBV-associated NK cell leukaemia/lymphoma.
Ohshima K; Haraokaa S; Ishihara S; Ohgami A; Yoshioka S; Suzumiya J; Kikuchi M
Leuk Lymphoma; 2002 Feb; 43(2):293-300. PubMed ID: 11999560
[TBL] [Abstract][Full Text] [Related]
24. Delineation of the 6p22 amplification unit in urinary bladder carcinoma cell lines.
Bruch J; Schulz WA; Häussler J; Melzner I; Brüderlein S; Möller P; Kemmerling R; Vogel W; Hameister H
Cancer Res; 2000 Aug; 60(16):4526-30. PubMed ID: 10969802
[TBL] [Abstract][Full Text] [Related]
25. Characterization of 3p, 5p, and 3q in two nasopharyngeal carcinoma cell lines, using region-specific multiplex fluorescence in situ hybridization probes.
Tjia WM; Sham JS; Hu L; Tai AL; Guan XY
Cancer Genet Cytogenet; 2005 Apr; 158(1):61-6. PubMed ID: 15771906
[TBL] [Abstract][Full Text] [Related]
26. Molecular delineation of the commonly deleted segment in mature B-cell lymphoid neoplasias with deletion of 7q.
Hernández JM; Schoenmakers EF; Dal Cin P; Michaux L; Van de Ven WJ; Van den Berghe H
Genes Chromosomes Cancer; 1997 Feb; 18(2):147-50. PubMed ID: 9115965
[TBL] [Abstract][Full Text] [Related]
27. Localization of deletion to a 300 Kb interval of chromosome 11q13 in cervical cancer.
Srivatsan ES; Chakrabarti R; Zainabadi K; Pack SD; Benyamini P; Mendonca MS; Yang PK; Kang K; Motamedi D; Sawicki MP; Zhuang Z; Jesudasan RA; Bengtsson U; Sun C; Roe BA; Stanbridge EJ; Wilczynski SP; Redpath JL
Oncogene; 2002 Aug; 21(36):5631-42. PubMed ID: 12165862
[TBL] [Abstract][Full Text] [Related]
28. Chromosomal changes detected by fluorescence in situ hybridization in patients with acute lymphoblastic leukemia.
Zhang L; Parkhurst JB; Kern WF; Scott KV; Niccum D; Mulvihill JJ; Li S
Chin Med J (Engl); 2003 Sep; 116(9):1298-303. PubMed ID: 14527352
[TBL] [Abstract][Full Text] [Related]
29. Fluorescence in situ hybridization detects frequent chromosome 9 deletions and aneuploidy in histologically normal urothelium of bladder cancer patients.
Obermann EC; Meyer S; Hellge D; Zaak D; Filbeck T; Stoehr R; Hofstaedter F; Hartmann A; Knuechel R
Oncol Rep; 2004 Apr; 11(4):745-51. PubMed ID: 15010867
[TBL] [Abstract][Full Text] [Related]
30. Mechanism and genotype-phenotype correlation of two proximal 6q deletions characterized using mBAND, FISH, array CGH, and DNA sequencing.
Vlckova M; Trkova M; Zemanova Z; Hancarova M; Novotna D; Raskova D; Puchmajerova A; Drabova J; Zmitkova Z; Tan Y; Sedlacek Z
Cytogenet Genome Res; 2012; 136(1):15-20. PubMed ID: 22156400
[TBL] [Abstract][Full Text] [Related]
31. Two regions of homozygous deletion clusters at chromosome band 9p21 in human lung cancer.
Hamada K; Kohno T; Takahashi M; Yamazaki M; Yamazaki M; Tashiro H; Sugawara C; Ohwada S; Sekido Y; Minna JD; Yokota J
Genes Chromosomes Cancer; 2000 Mar; 27(3):308-18. PubMed ID: 10679921
[TBL] [Abstract][Full Text] [Related]
32. Dual-probe fluorescence in situ hybridization assay for detecting deletions associated with VCFS/DiGeorge syndrome I and DiGeorge syndrome II loci.
Berend SA; Spikes AS; Kashork CD; Wu JM; Daw SC; Scambler PJ; Shaffer LG
Am J Med Genet; 2000 Apr; 91(4):313-7. PubMed ID: 10766989
[TBL] [Abstract][Full Text] [Related]
33. Molecular-cytogenetic analysis of fragmentation of chromosome 17 in the breast cancer cell line EFM-19.
Rogalla P; Helbig R; Drieschner N; Flohr AM; Krohn M; Bullerdiek J
Anticancer Res; 2002; 22(4):1987-92. PubMed ID: 12174875
[TBL] [Abstract][Full Text] [Related]
34. 6q terminal deletion syndrome associated with a distinctive EEG and clinical pattern: a report of five cases.
Elia M; Striano P; Fichera M; Gaggero R; Castiglia L; Galesi O; Malacarne M; Pierluigi M; Amato C; Musumeci SA; Romano C; Majore S; Grammatico P; Zara F; Striano S; Faravelli F
Epilepsia; 2006 May; 47(5):830-8. PubMed ID: 16686647
[TBL] [Abstract][Full Text] [Related]
35. Characterization of rearrangements involving 4q, 13q and 16q in hepatocellular carcinoma cell lines using region-specific multiplex-FISH probes.
Tjia WM; Hu L; Zhang MY; Guan XY
Cancer Lett; 2007 May; 250(1):92-9. PubMed ID: 17098359
[TBL] [Abstract][Full Text] [Related]
36. Cytogenetic and molecular analysis of 6q deletions in Burkitt's lymphoma cell lines.
Parsa NZ; Gaidano G; Mukherjee AB; Hauptschein RS; Lenoir G; Dalla-Favera R; Chaganti RS
Genes Chromosomes Cancer; 1994 Jan; 9(1):13-8. PubMed ID: 7507695
[TBL] [Abstract][Full Text] [Related]
37. Frequent deletions of 6q23-24 in B-cell non-Hodgkin's lymphomas detected by fluorescence in situ hybridization.
Zhang Y; Weber-Matthiesen K; Siebert R; Matthiesen P; Schlegelberger B
Genes Chromosomes Cancer; 1997 Apr; 18(4):310-3. PubMed ID: 9087572
[TBL] [Abstract][Full Text] [Related]
38. A 700-kb physical map of a region of 16q23.2 homozygously deleted in multiple cancers and spanning the common fragile site FRA16D.
Paige AJ; Taylor KJ; Stewart A; Sgouros JG; Gabra H; Sellar GC; Smyth JF; Porteous DJ; Watson JE
Cancer Res; 2000 Mar; 60(6):1690-7. PubMed ID: 10749141
[TBL] [Abstract][Full Text] [Related]
39. Early involvement of 6q in surface epithelial ovarian tumors.
Tibiletti MG; Bernasconi B; Furlan D; Riva C; Trubia M; Buraggi G; Franchi M; Bolis P; Mariani A; Frigerio L; Capella C; Taramelli R
Cancer Res; 1996 Oct; 56(19):4493-8. PubMed ID: 8813146
[TBL] [Abstract][Full Text] [Related]
40. Characterization of a complex chromosome rearrangement involving 6q in a melanoma cell line by chromosome microdissection.
Guan XY; Zhang HE; Zhou H; Sham JS; Fung JM; Trent JM
Cancer Genet Cytogenet; 2002 Apr; 134(1):65-70. PubMed ID: 11996799
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
